Reply to Douxfils, J.; Foidart, J.-M. Critical Considerations in the Interpretation of Bone Turnover Marker Data in Hormonal Contraceptive Users. Comment on “Tassi et al. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women. <i>Pharmaceuticals</i> 2025, <i>18</i>, 61”

অনুরূপ উপাদানগুলি

• Neuroendocrinological Aspects of a Tailored Hormonal Contraception
  অনুযায়ী: Christian Battipaglia, অন্যান্য
  প্রকাশিত: (2025-07-01)
• Reply to Douxfils, J.; Foidart, J.-M. Critical Considerations in the Interpretation of Bone Turnover Marker Data in Hormonal Contraceptive Users. Comment on “Tassi et al. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women. <i>Pharmaceuticals</i> 2025, <i>18</i>, 61”
  অনুযায়ী: Alice Tassi, অন্যান্য
  প্রকাশিত: (2025-09-01)
• The Role of Female Reproductive Hormones in the Association between Migraine and Breast Cancer: An Unanswered Question
  অনুযায়ী: Paola Tiberio, অন্যান্য
  প্রকাশিত: (2023-06-01)
• Real-world treatment patterns in patients with dysmenorrhea in Japan: a retrospective database study
  অনুযায়ী: Daisuke Goto, অন্যান্য
  প্রকাশিত: (2026-06-01)
• Factors That Influence Changes in Mammographic Density With Postmenopausal Hormone Therapy
  অনুযায়ী: Fang-Ping Chen, অন্যান্য
  প্রকাশিত: (2010-12-01)